Jie Lin

1.5k citations

55 papers · 1.0k indexed · h-index 21

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Cancer-related gene regulation

Papers in ⓘ

Cancer Research 28
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 9
- Cancer, Hypoxia, and Metabolism 5
Oncology 16
- Cancer-related Molecular Pathways 5

Co-authors: Min Yu (4 shared papers)Lei Ding (4 shared papers)Wen-Shan Lin (1 shared paper)Qinghua Cui (1 shared paper)Huan Gu (1 shared paper)Jiaqi Cao (1 shared paper)Ye Gu (2 shared papers)Kang Guo (2 shared papers)
Journals: Molecular Cancer Therapeutics (4 papers)Journal of Translational Medicine (3 papers)Cancer Research (3 papers)Oncology Reports (2 papers)Cancer Science (2 papers)
Partner nations: China United States Taiwan

In The Last Decade

Jie Lin

53 papers receiving 995 citations

Peers

Countries citing papers authored by Jie Lin

Since Specialization

Citations

This map shows the geographic impact of Jie Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Lin more than expected).

Fields of papers citing papers by Jie Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Lin. The network helps show where Jie Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Jie Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jie Lin Line = papers co-authored together Jie Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer Cells ·Lei Ding, Huan Gu, Xianhui Xiong, Hongshun Ao, Jiaqi Cao, Wen-Shan Lin, Min Yu, Jie Lin, Qinghua Cui	2019	117
2	SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling Cancer Science ·Chong Zeng, Jie Lin, Ketao Zhang, Huohui Ou, Ke Shen, Qingbo Liu, Zibo Wei, Xinhuai Dong, Xiaokang Zeng, Liming Zeng, Weidong Wang, Jie Yao	2022	94
3	TUSC3 promotes colorectal cancer progression and epithelial–mesenchymal transition (EMT) through WNT/β‐catenin and MAPK signalling The Journal of Pathology ·Ye Gu, Qian Wang, Kang Guo, Weizhao Qin, Wenting Liao, Shuang Wang, Yanqing Ding, Jie Lin	2016	80
4	Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL Molecular Therapy — Nucleic Acids ·Ting Yu, Lingyu Ran, Hongwen Zhao, Pin Yin, Wei Li, Jie Lin, Hui Mao, Dongping Cai, Qiang Ma, Xiaojuan Pan, Xiaolin Wang, Jingjing Wu, Hao Zeng, Weijun Zhang, Dongshui Lu, Ping Luo, Quanming Zou, Bin Xiao	2021	63
5	[Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas]. PubMed ·Han kui Chen, Xiao qiong Liu, Jie Lin, Tian yu Chen, Qi Feng, Yi Zeng	2002	37
6	TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells Oncology Reports ·Qianqian Liu, Hong‐Yu Huo, Song Harris Ao, Ting Liu, Yang Li, Zai‐Yi Fei, Zhiqiang Zhang, Lei Ding, Qinghua Cui, Jie Lin, Min Yu, Wei Xiong	2020	35
7	Malvidin-3-galactoside from blueberry suppresses the growth and metastasis potential of hepatocellular carcinoma cell Huh-7 by regulating apoptosis and metastases pathways Food Science and Human Wellness ·Jie Lin, Jinlong Tian, Chi Shu, Zhen Cheng, Yunen Liu, Weisheng Wang, Ruihai Liu, Bin Li, Yuehua Wang	2020	33
8	Identification of valid reference genes for mRNA and microRNA normalisation in prostate cancer cell lines Scientific Reports ·Hui Zhao, Tengfei Ma, Jie Lin, Linlin Liu, Weijie Sun, Lixia Guo, Siqi Wang, Newton O. Otecko, Ya‐Ping Zhang	2018	32
9	De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model Cancer Research ·James Watters, Chun Cheng, Pradip K. Majumder, Ruojie Wang, Sireesha Yalavarthi, Carol Meeske, Lingxin Kong, Wenping Sun, Jie Lin, Joerg Heyer, Chris Ware, Christopher Winter, John F. Reilly, Tim Demuth, Steve Clark, M. Isabel Chiu, Murray O. Robinson, Nancy E. Kohl, Karuppiah Kannan	2009	31
10	The Mechanism of DNA Methylation and miRNA in Breast Cancer International Journal of Molecular Sciences ·Lingyuan Ma, Chenyu Li, Hanlin Yin, Jiashu Huang, Shenghao Yu, Jin Zhao, Yongxu Tang, Min Yu, Jie Lin, Lei Ding, Qinghua Cui	2023	31
11	Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application Cell Reports Medicine ·Xiaoxue Ren, Mingle Huang, Weixiang Weng, Yubin Xie, Yifan Wu, Shenghua Zhu, Ying Zhang, Dongming Li, Jiaming Lai, Shunli Shen, Jie Lin, Ming Kuang, Xiaoxing Li, Jun Yu, Lixia Xu	2023	29
12	Overexpression of Cdk6–cyclin D3 highly sensitizes cells to physical and chemical transformation Oncogene ·Qiuhong Chen, Jie Lin, Shigeki Jinno, Hiroto Okayama	2003	29
13	LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation Journal of Translational Medicine ·Rui Cai, Ping Wang, Xin Zhao, Xiansheng Lu, Ruxia Deng, Xiaoyu Wang, Zhaoji Su, Chang Hong, Jie Lin	2020	27
14	SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner Journal of Translational Medicine ·Xiaoyu Wang, Xiansheng Lu, Ping Wang, Qiaoyu Chen, Le Xiong, Minshan Tang, Chang Hong, Xiaowen Lin, Kaixi Shi, Li Liang, Jie Lin	2022	27
15	Blueberry malvidin-3-galactoside modulated gut microbial dysbiosis and microbial TCA cycle KEGG pathway disrupted in a liver cancer model induced by HepG2 cells Food Science and Human Wellness ·Zhen Cheng, Jie Lin, Ningxuan Gao, Xiyun Sun, Xianjun Meng, Ruihai Liu, Yunen Liu, Weisheng Wang, Bin Li, Yuehua Wang	2020	27
16	Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor. PubMed ·Shuang Wang, Minhui Yang, Xiaoyan Wang, Jie Lin, Yan-qing Ding	2014	24
17	The Dual Role of Circular RNAs as miRNA Sponges in Breast Cancer and Colon Cancer Biomedicines ·Jiashu Huang, Shenghao Yu, Lei Ding, Lingyuan Ma, Hongjian Chen, Hui Zhou, Yayan Zou, Min Yu, Jie Lin, Qinghua Cui	2021	23
18	microRNA-29b: an Emerging Player in Human Cancer Asian Pacific Journal of Cancer Prevention ·Hao Liu, Bin Wang, Jie Lin, Liang Zhao	2014	21
19	Pipelines for cross-species and genome-wide prediction of long noncoding RNA binding Nature Protocols ·Jie Lin, Yujian Wen, Sha He, Xiaoxue Yang, Hai Zhang, Hao Zhu	2019	20
20	Prodrug thiamine analogs as inhibitors of the enzyme transketolase Bioorganic & Medicinal Chemistry Letters ·Yvan Le Huérou, Indrani W. Gunawardana, Allen A. Thomas, Steven A. Boyd, Jason De Meese, Walter E. DeWolf, Steven S. Gonzales, May Han, Laura Hayter, Tomas Kaplan, Christine Lemieux, Patrice Lee, Jed Pheneger, G Pöch, Todd T. Romoff, Francis Sullivan, Solly Weiler, S. Kirk Wright, Jie Lin	2007	20

About Jie Lin

Jie Lin is a scholar working on Cancer Research, Oncology, Molecular Biology, Biochemistry and Biological Psychiatry, having authored 55 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (9 papers), MicroRNA in disease regulation (9 papers), Ferroptosis and cancer prognosis (8 papers), Circular RNAs in diseases (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related Molecular Pathways (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (473 citations), Molecular Biology (749 citations), Oncology (185 citations), Pulmonary and Respiratory Medicine (169 citations) and Biochemistry (26 citations). Jie Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Min Yu, Lei Ding, Wen-Shan Lin, Qinghua Cui, Huan Gu, Jiaqi Cao, Ye Gu, Kang Guo, Yanqing Ding and Wenting Liao. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Translational Medicine, Cancer Research, Oncology Reports and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact